Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NuVasive, Inc.
  6. Summary
    NUVA   US6707041058

NUVASIVE, INC.

(NUVA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
56.06(c) 57.87(c) 58.09(c) 57.97(c) 57.57(c) Last
644 941 477 000 481 176 430 666 470 332 Volume
-0.85% +3.23% +0.38% -0.21% -0.69% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 188 M - -
Net income 2021 26,3 M - -
Net Debt 2021 611 M - -
P/E ratio 2021 103x
Yield 2021 -
Sales 2022 1 283 M - -
Net income 2022 72,8 M - -
Net Debt 2022 536 M - -
P/E ratio 2022 38,1x
Yield 2022 -
Capitalization 2 974 M 2 974 M -
EV / Sales 2021 3,02x
EV / Sales 2022 2,74x
Nbr of Employees 2 700
Free-Float 88,0%
More Financials
Company
NuVasive, Inc. is a developer of specialty spinal implants into a global medical technology company that is delivering procedurally integrated solutions for spine surgery. The Company's portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, and intraoperative neuromonitoring technology and service offerings. The... 
More about the company
Ratings of NuVasive, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about NUVASIVE, INC.
10/14NUVASIVE : Launches Latest Porous PEEK Implant for Posterior Spine Surgery
PR
10/14NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
CI
09/30NUVASIVE : Announces First Commercial Cases Utilizing the Pulse Platform
PR
09/30NuVasive Announces First Commercial Cases Utilizing the Pulse Platform
CI
09/23NUVASIVE : Opens East Coast Experience Center in New York Metropolitan Area
PR
09/23NuVasive, Inc. Opens East Coast Experience Center in New York Metropolitan Area
CI
09/13NUVASIVE INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/11NUVASIVE : Morgan Stanley 19th Annual Global Healthcare Conference
PU
09/09NuVasive, Inc. Simplify Cervical Disc Data Publishes in International Journal of Spine ..
CI
09/01NUVASIVE : Announces New Executive Leadership Roles (Form 8-K)
PU
09/01NUVASIVE INC : Other Events (form 8-K)
AQ
09/01NUVASIVE : Names Technology, Commerce Chiefs
MT
09/01NUVASIVE : Announces New Executive Leadership Roles
PR
09/01NuVasive, Inc. Announces Executive Changes
CI
08/30NUVASIVE : to Present at Upcoming Investor Conference
PR
More news
News in other languages on NUVASIVE, INC.
2019L'Europe finit en nette hausse, espoir sur le commerce et les banques
2019Les valeurs à suivre à Paris et en Europe (actualisé)
2019PROTHÈSES : Smith&Nephew veut racheter l'américain NuVasive
2013NuVasive(R) baut sein Führungsteam in Europa weiter aus
2013NuVasive(R) nimmt an der 8. Jahrestagung der Deutschen Wirbelsäulengesellschaft teil
More news
Analyst Recommendations on NUVASIVE, INC.
More recommendations
Chart NUVASIVE, INC.
Duration : Period :
NuVasive, Inc. Technical Analysis Chart | NUVA | US6707041058 | MarketScreener
Technical analysis trends NUVASIVE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 57,57 $
Average target price 72,50 $
Spread / Average Target 25,9%
EPS Revisions
Managers and Directors
J. Christopher Barry Chief Executive Officer & Director
Matthew K. Harbaugh Chief Financial Officer & Executive Vice President
Daniel J. Wolterman Chairman
Kyle Malone VP-Clinical, Medical & Regulatory Affairs
Aviva McPherron Vice President-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
NUVASIVE, INC.2.20%2 974
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC5.08%165 656
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815